Introduction
According to the American Breast Cancer Society, mortality rates linked to the breast cancer in the United States have dropped between 1989-2015 and are currently stagnating for women aged below 50 years [1] . The World Health Organization (WHO) attributes this to early detection through screening and awareness efforts, as well as breakthroughs in treatment [2] . Nevertheless, breast cancer is one of the leading causes of mortality in women, second only to lung cancer. Surveillance data from the American Cancer Society predicts that 252,710 new cases of invasive and 63,410 of non-invasive (in situ) breast cancer are expected to be diagnosed across the US in 2017. About 40,610 women are expected to die as a result. Many new cases from low-and middleincome countries are diagnosed in late stages [3] . In Eastern Europe, invasive lobular carcinoma (ILC) is the second most prevalent type of breast cancer after invasive ductal carcinoma (IDC) [4] . While prevention remains an important tool for risk reduction in developed countries, the WHO recognizes population-based screening as the cornerstone of cancer control in limited resource settings with weak health systems. Mammography screening is associated with reduction in breast cancer death rates, being the most cost-effective screening tool [5, 6] .
The Breast Imaging Reporting and Data System (BI-RADS) is a framework created by the American College of Radiology (ACR) to standardize the terminology used in mammographic, magnetic resonance imaging (MRI), and breast ultrasound (US) reports [7] . BI-RADS subdivisions allow quantification of malignancy odds in lesions, increasing the quality of risk assessment in breast cancer [8, 9] . Breast US is widely used as an adjunct to mammography in screening [10] . In high-risk women, the diagnostic accuracy of US and mammography combined is superior to mammography alone [11] . ILC are sometimes difficult to identify or can be mammographically occult [12] . Small ILC lesions may have subtle US appearance (for example mimicking diffuse mastopathy) and are difficult to visualize. The sensitivity of ultrasound in ILC detection varies between 68-98% in different studies [13] [14] [15] .
Elastography is an imaging technique that allows quantification of tissue stiffness. US elastography imaging (EI) individuates benign and malignant breast lesions with high sensitivity and specificity [16] [17] [18] [19] [20] . A 2015 study concluded that shear-wave elastography (SWE) can diagnose lobular cancers that have benign findings on conventional imaging [21] . Strain elastography (SE) scores are associated with breast tumor grades [22] . Nevertheless, to our knowledge there are limited studies that explore the added value of SE in small ILC lesions [23] .
Correct classification of lesions into BI-RADS categories is essential for predicting the presence of malignancy [8, 24] . Therefore, the purpose of this study was to determine whether SE has differential impact on BI-RADS classification depending on ILC lesion sizes.
Materials and methods

Study procedures
This cross-sectional retrospective study was conducted based on international ethical principles for medical research involving human subjects and approved by our Institutional Review Board. Between January 2010 and January 2017, reports of patients referred for screening or diagnosis US were reviewed. Only patients with biopsy confirmed ILC diagnosis and SE examinations were included in the study. Cases with associated IDC or Ductal Carcinoma in Situ were excluded. Our analysis controlled for BI-RADS categories 1, 2, and blue-greenred (BGR) on Tsukuba elasticity score, as well as patients undergoing neoadjuvant therapy (BI-RADS 6).
All examinations were performed by a radiologist with 10 years of experience in SE on a HI VISION Ascendus (Hitachi Ltd., Tokyo, Japan) machine with a Wide Band (6.5-13 MHz) linear probe and an EUB-6500 HiVision (Hitachi Ltd., Tokyo, Japan) machine with linear probe (36 mm; 5.0-10.0 MHz). The elastogram was obtained in the supine position; a slight, rhythmic compression-decompression movement was applied to the area of interest, aligning the scan plane to the skin surface, anterior margin of the lesion and the chest wall. Techniques were displayed side by side during a real-time elastosonographic examination and classified according to the Ueno-Itoh adaptation of the Tsukuba elasticity score [25, 26] , taking into account ACR Appropriateness Criteria [27] . Good quality SE images were acquired by applying minimal transducer pressure, to avoid distorting glandular tissue signal. Lesion size was measured in B-mode to avoid differences attributable to elasticity imaging [28] . A 14-gauge core needle and Magnum Bard device (Bard, Inc, NJ, USA) was used to harvest image-guided biopsies. Histologic diagnosis was then extracted from pathologic reports.
B-mode and SE images were reviewed separately for each lesion and 2 BI-RADS scores were recorded for Bmode and SE enhanced examinations. The patients were classified according to the fifth edition of the BI-RADS lexicon, which includes elastographic findings. The system classifies lesions as soft, intermediate, or hard. SE was used to increase BI-RADS scores, taking into account lesion stiffness [29] . Only lesions that appeared hard on SE (4 or 5 elasticity score) were classified in a higher BI-RADS category. Lesions with lower elasticity scores were classified as soft (1 or 2 Tsukuba score) or intermediate (3 Tsukuba score).
We defined focality as the region in which breast cancer was located: unifocal -one tumor; multifocal -two or more separate invasive tumors in the same quadrant of the breast; multicentric -two or more separate invasive tumors that occupy more than one quadrant of the same breast [30] .
Statistical Analysis
Data was analyzed by a single operator using SPSS V.23 (IBM, NY, USA). The main variables included in the analysis were lesion size and BI-RADS classification (with and without SE). A per lesion analysis was conducted taking into account multiple lesions per patient as a grouping variable controlled in the regression model. We calculated descriptive statistics for all study variables: number, frequency, mean and standard deviation (SD). We numerically recoded BI-RADS variables and used a Wilcoxon signed rank test to establish a statistically significant difference between BI-RADS classification before and after SE examination. The Wilcoxon signed-rank test is the nonparametric test equivalent to the dependent t-test that does not assume normality in the data. Frequencies of the numeric difference in BI-RADS scores between examinations were interpreted to identify the quantitative impact of SE on the BI-RADS scores in our sample. Subsequently, a binary variable was computed depending on the presence of statistically significant differences in BI-RADS scores (values 0 and 1, accordingly). The relationship between size (continuous, independent variable) and BI-RADS difference (binary, dependent variable) was tested using binary logistic regression. Afterwards, an ROC curve (nonparametric assumption, CI=95%) using lesion size (continuous) as test variable and BI-RADS difference (binary) as state variable was used to calculate the optimal cut-off point. Sensitivity and specificity were weighed equally in the decision process. After coordinating the points of the curve, Youden's J statistic was calculated and compared for each entry, resulting in a clear threshold value for lesion size. To control for possible confounders, the analysis was stratified according to variables collected from the study sample: age, focality, clinical assessment, heredo-collateral antecedents (HCA -self-reported first-degree female relatives diagnosed with breast cancer), B-mode and Doppler US examination. We set the level of significance to p<0.05, or confidence interval at 95%.
Results
The study group comprised 152 females with a total of 180 malignant lesions (biopsy-confirmed ILC) between ages 33-82 (mean±SD, 56.6±10.8). The histological subtypes of ILC were luminal A (n=126), luminal B (n=50), triple negative (n=3) and HER2+ (n=1). Tsukuba elasticity scores ranged from 1 to 5 (mean ± SD, 4.8±0.6). Tumors included in the analysis measured between 2-75 mm (mean±SD, 22.5±15.1). Values pertaining to SE, Bmode and Doppler examination, focality and clinical assessment are described in Table I. SE improved BI-RADS classification in 54 (30.00%) of tumors (Table II) . The Wilcoxon signed rank test established a statistically significant difference (Z=-6.629, p<0.000) between BI-RADS classifications before and after SE evaluation (fig 1, fig 2) . Out of the entire sample included in the analysis (n=180), SE increased BI- The data are expressed as number (%); SE -strain elastography; n -number of malignant lesions An ROC curve was used to determine a cut-off point for lesion size in relationship with BI-RADS change after SE (p<0.000; AUC=0.886). The largest Youden index was observed at 13 mm ILC size (J=0.670).
Finally, a binary logistic regression was performed to assess the relationship between tumor size and difference in BI-RADS classification. Results were statistically significant (χ 2 =123.017, p<0.000). The model explained between 49.5%-70.5% (Nagelkerke R 2 ) of the variance in the dependent variable and correctly classified 90.6% of cases. Small lesion (<13 mm) sizes were 17.92% more likely to influence BI-RADS classification (Fig. 3 ). We noted a smaller impact of tumors present in clinical assessment on BI-RADS classification (Exp(B)=0.64, p<0.001). Remaining independent variables (age, breast type, focality, clinical assessment, HCA, B-mode, and Doppler US examination) did not yield statistically significant values in the regression model.
Discussions
There is growing evidence pertaining to the importance of breast elastography in the BI-RADS classification [31] . SE and SWE in conjunction with BI-RADS are proven to increase diagnostic specificity and sensitivity [32] . Additionally, a relationship has been found between the elasticity imaging/B-mode ratio on SE and tumor grades in breast cancer [22] . A recent preliminary study has indicated that Contrast Enhanced Ultrasound (CEUS) provides superior diagnostic performance in sub-centimetre breast lesions, offering promising alternatives to biopsy [33] . Given these updates in the field of sonoelastography, we set out to explore the relationship between lesion size and the influence of SE on ILC classification, in order to identify an optimal size threshold at which SE adds significantly more value to the examination.
Due to diffuse growth patterns and the absence of microcalcifications, ILC is often times mammographically occult (between 21-43%) [12, 14, 34] . Here lies the importance of breast US as an adjunct in breast cancer screening. Sim et al describes 4 cases of ILC that were normal at both mammography and greyscale US, but suspicious on SWE [21] .
Similarly, our study builds current knowledge regarding elastographic imaging by demonstrating the added value of SE in small size lesions. Our study establishes that at 13 mm threshold in tumor size, SE is significantly more likely to influence BI-RADS classification. The binary logistic regression analysis brings high confidence evidence that our sample is not a random occurrence and is adjusted to relevant co-variates.
Another factor which this analysis controlled was the quality of B-mode visualization in small lesions. If the Bmode had been poorly visualized in small lesions, the impact of SE would have falsely accounted for our findings. We strongly reject this hypothesis because SE only marginally increased lesion classification, with most cases (68.88%) with all cases being upgraded only to the next BI-RADS classification. If poor quality of small lesion B-mode was an issue, we would have observed higher discrepancies between BI-RADS scores that cannot be explained from a clinical perspective.
The potential to target the enhancement of BI-RADS classification via SE to small ILC is extremely important in clinical practice because it adds efficiency to the real-time sonographic examination. In a 955-patient study of Fleury et al [31] the addition of elastography to BI-RADS was proved to significantly increase diagnostic accuracy (76.64% to 91.39%) and specificity (from 72.07% to 80.65%) of US in the assessment of breast lesions. As shown in our study, elastograms obtained aided the senologist in differentiating 3-4A, 4A-4B, 4B-4C, or 4C-5 BI-RADS categories, but mostly in <13 mm lesions. Therefore, the use of elastography in such lesions may have a critical role in patient management, including the decision whether to biopsy a lesion or not [35] , according to BI-RADS guidelines.
A higher grade ILC can appear concealed on breast US due to microlobulated margins and acoustic enhancement. In this case, a higher Tsukuba score may raise question marks. Especially in small tumors with imprecisely delineated margins, this may trigger an important re-evaluation of the breast US and conjunct examinations in order to identify further malignancies or axillary lymphadenopathy. In this scenario, the screening process is significantly improved, positively impacting the treatment options and clinical management of the disease. Finally, an increased level of suspicion from the radiologist may provide additional information of value to the pathologist, as the differentiation between different tumor grades can be challenging and can vary among pathologists [22] .
We must acknowledge that our research design is limited in its retrospective and cross-sectional approach. The study sample is conveniently drawn from a single outpatient clinic. Low breast cancer screening rates in Romania, along with differences in access to healthcare may skew the socioeconomic profile of study participants [36] . Moreover, the implication of a single observer is an additional source of potential bias. However, strict data collection methodology was enforced in order to limit reporting errors. Finally, the current study design may be improved (longitudinal/cohort) in order to increase inferential power. Future research opportunities may focus on integrating recent findings related to SE and SWE in a standardized protocol that provides a much needed consensus on the ideal breast US approach. An interesting additional avenue of research would be exploring the relationship between SE and Magnetic Resonance Elastography (MRE).
In conclusion, we report that SE impacts BI-RADS classification in ILC lesions smaller than 13mm. The need to perform SE as a standard component of breast cancer screening has cost implications. Our results require stronger sampling methods and mediation analysis in order to confirm study findings.
